Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

NASDAQ:MDB - Nasdaq - US60937P1066 - Common Stock

257.86  +4.75 (+1.88%)

After market: 260.746 +2.89 (+1.12%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MDB. MDB was compared to 82 industry peers in the IT Services industry. The financial health of MDB is average, but there are quite some concerns on its profitability. MDB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MDB had positive earnings in the past year.
MDB had a positive operating cash flow in the past year.
MDB had negative earnings in each of the past 5 years.
In multiple years MDB reported negative operating cash flow during the last 5 years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

The Return On Assets of MDB (-6.21%) is worse than 67.09% of its industry peers.
The Return On Equity of MDB (-13.34%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.21%
ROE -13.34%
ROIC N/A
ROA(3y)-10.67%
ROA(5y)-12.84%
ROE(3y)-36.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K 40K 60K 80K

1.3 Margins

MDB's Gross Margin of 73.86% is amongst the best of the industry. MDB outperforms 91.14% of its industry peers.
In the last couple of years the Gross Margin of MDB has remained more or less at the same level.
MDB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.22%
GM growth 5Y0.64%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MDB has more shares outstanding
MDB has more shares outstanding than it did 5 years ago.
MDB has a better debt/assets ratio than last year.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 6.51 indicates that MDB is not in any danger for bankruptcy at the moment.
MDB has a Altman-Z score of 6.51. This is in the better half of the industry: MDB outperforms 78.48% of its industry peers.
The Debt to FCF ratio of MDB is 7.87, which is on the high side as it means it would take MDB, 7.87 years of fcf income to pay off all of its debts.
MDB has a Debt to FCF ratio of 7.87. This is comparable to the rest of the industry: MDB outperforms 41.77% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MDB is not too dependend on debt financing.
The Debt to Equity ratio of MDB (0.02) is better than 81.01% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 7.87
Altman-Z 6.51
ROIC/WACCN/A
WACC11.34%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.70 indicates that MDB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.70, MDB is in line with its industry, outperforming 56.96% of the companies in the same industry.
MDB has a Quick Ratio of 1.70. This is a normal value and indicates that MDB is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.70, MDB perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.95% over the past year.
Looking at the last year, MDB shows a very strong growth in Revenue. The Revenue has grown by 20.78%.
The Revenue has been growing by 44.52% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)6.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y41.79%
Revenue growth 5Y44.52%
Sales Q2Q%22.28%

3.2 Future

MDB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.59% yearly.
MDB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.61% yearly.
EPS Next Y-10.68%
EPS Next 2Y1.06%
EPS Next 3Y8.36%
EPS Next 5Y27.59%
Revenue Next Year19.08%
Revenue Next 2Y18.3%
Revenue Next 3Y19.13%
Revenue Next 5Y18.61%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MDB is valuated quite expensively with a Price/Earnings ratio of 79.83.
The rest of the industry has a similar Price/Earnings ratio as MDB.
When comparing the Price/Earnings ratio of MDB to the average of the S&P500 Index (28.29), we can say MDB is valued expensively.
A Price/Forward Earnings ratio of 76.28 indicates a quite expensive valuation of MDB.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDB is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.44, MDB is valued quite expensively.
Industry RankSector Rank
PE 79.83
Fwd PE 76.28
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MDB is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 129.77
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.06%
EPS Next 3Y8.36%

More info and screens

0

5. Dividend

5.1 Amount

MDB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (1/21/2025, 8:13:30 PM)

After market: 260.746 +2.89 (+1.12%)

257.86

+4.75 (+1.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-09 2024-12-09/amc
Earnings (Next)N/A N/A
Inst Owners97%
Inst Owner Change0.35%
Ins Owners0.77%
Ins Owner Change-1.28%
Market Cap19.20B
Analysts78.97
Price Target384.66 (49.17%)
Short Float %2.37%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)54.1%
Min EPS beat(2)40.33%
Max EPS beat(2)67.86%
EPS beat(4)4
Avg EPS beat(4)54.31%
Min EPS beat(4)27.24%
Max EPS beat(4)81.8%
EPS beat(8)8
Avg EPS beat(8)163.03%
EPS beat(12)12
Avg EPS beat(12)161.19%
EPS beat(16)16
Avg EPS beat(16)132.51%
Revenue beat(2)2
Avg Revenue beat(2)3.64%
Min Revenue beat(2)1.99%
Max Revenue beat(2)5.3%
Revenue beat(4)4
Avg Revenue beat(4)3.35%
Min Revenue beat(4)1.47%
Max Revenue beat(4)5.3%
Revenue beat(8)8
Avg Revenue beat(8)4.7%
Revenue beat(12)12
Avg Revenue beat(12)5.68%
Revenue beat(16)16
Avg Revenue beat(16)6.13%
PT rev (1m)9.87%
PT rev (3m)10.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.84%
EPS NY rev (1m)0%
EPS NY rev (3m)21.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 79.83
Fwd PE 76.28
P/S 10.02
P/FCF 129.77
P/OCF 124.47
P/B 12.79
P/tB 13.42
EV/EBITDA N/A
EPS(TTM)3.23
EY1.25%
EPS(NY)3.38
Fwd EY1.31%
FCF(TTM)1.99
FCFY0.77%
OCF(TTM)2.07
OCFY0.8%
SpS25.73
BVpS20.17
TBVpS19.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.21%
ROE -13.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.86%
FCFM 7.72%
ROA(3y)-10.67%
ROA(5y)-12.84%
ROE(3y)-36.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.22%
GM growth 5Y0.64%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 7.87
Debt/EBITDA N/A
Cap/Depr 32.8%
Cap/Sales 0.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z 6.51
F-Score5
WACC11.34%
ROIC/WACCN/A
Cap/Depr(3y)36.1%
Cap/Depr(5y)38.88%
Cap/Sales(3y)0.62%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20.83%
EPS Next Y-10.68%
EPS Next 2Y1.06%
EPS Next 3Y8.36%
EPS Next 5Y27.59%
Revenue 1Y (TTM)20.78%
Revenue growth 3Y41.79%
Revenue growth 5Y44.52%
Sales Q2Q%22.28%
Revenue Next Year19.08%
Revenue Next 2Y18.3%
Revenue Next 3Y19.13%
Revenue Next 5Y18.61%
EBIT growth 1Y-13.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.3%
EBIT Next 3Y22.38%
EBIT Next 5Y28.7%
FCF growth 1Y656.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1033.33%
OCF growth 3YN/A
OCF growth 5YN/A